Patents by Inventor GENEVIÈVE ROUSSEAU

GENEVIÈVE ROUSSEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CRISPR polynucleotides and polypeptides and methods of use
    Patent number: 11732251
    Abstract: Methods and compositions are provided for the use of anti-CRISPR (ACR) proteins in plants, including modulation of Cas endonuclease activity, improvement of frequency of homologous recombination, control of Cas endonuclease activity during various cell cycles, spatial and/or temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, as well as reduction of off-target polynucleotide cleavage.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: August 22, 2023
    Assignees: DUPONT NUTRITION BIOSCIENCES APS, UNIVERSITE LAVAL (CANADA)
    Inventors: Christophe Fremaux, Philippe Horvath, Alexander Hynes, Marie-Laurence Lemay, Sylvain Moineau, Dennis A. Romero, Geneviève Rousseau, Joshua K Young
  • Anti-CRISPR genes and proteins and methods of use
    Patent number: 11530405
    Abstract: The invention relates to anti-CRISPR genes and anti-CRISPR proteins, and their uses in various biotechnology applications.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: December 20, 2022
    Assignees: DUPONT NUTRITION BIOSCIENCES APS, UNIVERSITE LAVAL (CANADA)
    Inventors: Christophe Fremaux, Philippe Horvath, Dennis A. Romero, Sylvain Moineau, Alexander Hynes, Geneviève Rousseau
  • NOVEL ANTI-CRISPR POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE
    Publication number: 20200190492
    Abstract: Methods and compositions are provided for the use of anti-CRISPR (ACR) proteins in plants, including modulation of Cas endonuclease activity, improvement of frequency of homologous recombination, control of Cas endonuclease activity during various cell cycles, spatial and/or temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, as well as reduction of off-target polynucleotide cleavage.
    Type: Application
    Filed: April 24, 2018
    Publication date: June 18, 2020
    Inventors: CHRISTOPHE FREMAUX, PHILIPPE HORVATH, ALEXANDER HYNES, MARIE-LAURENCE LEMAY, SYLVAIN MOINEAU, DENNIS A. ROMERO, GENEVIÈVE ROUSSEAU
  • NOVEL ANTI-CRISPR GENES AND PROTEINS AND METHODS OF USE
    Publication number: 20200040328
    Abstract: The invention relates to anti-CRISPR genes and anti-CRISPR proteins, and their uses in various biotechnology applications
    Type: Application
    Filed: April 24, 2018
    Publication date: February 6, 2020
    Inventors: CHRISTOPHE FREMAUX, PHILIPPE HORVATH, DENNIS A. ROMERO, SYLVAIN MOINEAU, ALEXANDER HYNES, GENEVIEVE ROUSSEAU
  • Novel-17-spirosultines their corresponding hydroxy acids and compositions thereof
    Patent number: 4093720
    Abstract: Novel 17-spirosultines and their corresponding .gamma.-hydroxy acids of the formula ##STR1## wherein A is hydrogen and B is alkyl of 1 to 4 carbon atoms in the .alpha.- or .beta.-position or A and B form a methylene group in the 6.alpha., 7.alpha.- or 6.beta., 7.beta.-position and X and Y form a group of the formula ##STR2## or X is OH and Y is ##STR3## and M is selected from the group consisting of hydrogen, --NH.sub.4 and an alkali metal cation having antialdosterone activity and their preparation and novel intermediates therefore.
    Type: Grant
    Filed: March 14, 1977
    Date of Patent: June 6, 1978
    Assignee: Roussel Uclaf
    Inventors: Genevieve Rousseau, Vesperto Torelli
  • Novel steroids and their use
    Patent number: 3971777
    Abstract: Novel (17.alpha.)-steroids derivatives optical active isomers or mixtures thereof of the formula ##SPC1##Wherein R is selected from the group consisting of hydrogen and methyl, R.sub.1 is alkyl of 1 to 4 carbon atoms, Z is selected from the group consisting of hydrogen and ##EQU1## of .alpha.-configuration; R.sub.2 is alkyl of 1 to 4 carbon atoms, the dotted lines in the A and B rings represent optional 1 or 2 double bonds in the 1(2) position when R is methyl and in the 6(7) position when Z is hydrogen and X and Y together form the group ##EQU2## and when X is OH, Y is ##EQU3## and M is selected from the group consisting of hydrogen, --NH.sub.4 and alkali metals which have antialdosteronic activity and their preparation.
    Type: Grant
    Filed: September 8, 1975
    Date of Patent: July 27, 1976
    Assignee: Roussel-UCLAF
    Inventors: Genevieve Rousseau, Vesperto Torelli